Website Header with Language Selector and Dropdowns

Halometasone
CAT No: CL-HLMT-001 CAS No: 50629-82-8 Mol Wt: 444.9 Mol F: C22H27ClF2O5 Inv Status: Custom Synthesis
Chemical Name: (6S,8S,9R,10S,11S,13S,14S,16R,17R)-2-chloro-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one
Halometasone Impurity 1
CAT No: CL-HLMT-002 CAS No: NA Mol Wt: 444.9 Mol F: C22H27ClF2O5 Inv Status: Custom Synthesis
Chemical Name: 2-((6S,8S,9R,10S,11S,13S,14S,16R,17R)-2-Chloro-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-hydroxyacetaldehyde
Halometasone Impurity 10
CAT No: CL-HLMT-003 CAS No: NA Mol Wt: 486.9 Mol F: C24H29ClF2O6 Inv Status: Custom Synthesis
Chemical Name: 2-((6S,8S,9R,10S,11S,13S,14S,16S,17R)-2-Chloro-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
Halometasone Impurity 11
CAT No: CL-HLMT-004 CAS No: NA Mol Wt: 458.9 Mol F: C22H25ClF2O6 Inv Status: Custom Synthesis
Chemical Name: 2-((6S,8S,9R,10S,11S,13S,14S,16R,17R)-2-Chloro-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetic acid
Halometasone Impurity 2
CAT No: CL-HLMT-005 CAS No: 136132-00-8 Mol Wt: 384.8 Mol F: C20H23ClF2O3 Inv Status: Custom Synthesis
Chemical Name: (6S,8S,9R,10S,11S,13S,14S,16R)-2-Chloro-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione
Halometasone Impurity 3
CAT No: CL-HLMT-006 CAS No: 80157-55-7 Mol Wt: 430.9 Mol F: C21H25ClF2O5 Inv Status: Custom Synthesis
Chemical Name: (6S,8S,9R,10S,11S,13S,14S,16R,17R)-2-Chloro-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid
Halometasone Impurity 4
CAT No: CL-HLMT-007 CAS No: NA Mol Wt: 442.9 Mol F: C22H25ClF2O5 Inv Status: Custom Synthesis
Chemical Name: 2-((6S,8S,9R,10S,11S,13S,14S,16R,17R)-2-Chloro-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetaldehyde
Halometasone Impurity 5
CAT No: CL-HLMT-008 CAS No: NA Mol Wt: 444.9 Mol F: C22H27ClF2O5 Inv Status: Custom Synthesis
Chemical Name: (6S,8S,9R,10S,11S,13S,14S,16R,17R)-2-Chloro-17-((Z)-1,2-dihydroxyvinyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one
Halometasone Impurity 6
CAT No: CL-HLMT-009 CAS No: NA Mol Wt: 460.9 Mol F: C22H27ClF2O6 Inv Status: Custom Synthesis
Chemical Name: 2-((6S,8S,9R,10S,11S,13S,14S,16R,17R)-2-Chloro-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-hydroxyacetic acid
Halometasone Impurity 7
CAT No: CL-HLMT-010 CAS No: NA Mol Wt: 557.8 Mol F: C24H29Cl3F2O6 Inv Status: Custom Synthesis
Chemical Name: 2-Oxo-2-((6S,8S,9R,10R,11S,13S,14S,16R,17R)-2,4,5-trichloro-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-17-yl)ethyl acetate
Halometasone Impurity 7
CAT No: CL-HLMT-011 CAS No: 67212-85-5 Mol Wt: 426.9 Mol F: C22H25ClF2O4 Inv Status: Custom Synthesis
Chemical Name: (Z)-2-((6S,8S,9R,10S,11S,13S,14S,16R)-2-Chloro-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-3,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-17H-cyclopenta[a]phenanthren-17-ylidene)-2-hydroxyacetaldehyde
Halometasone Impurity 9
CAT No: CL-HLMT-012 CAS No: 23961-24-2 Mol Wt: 523.4 Mol F: C24H30Cl2F2O6 Inv Status: Custom Synthesis
Chemical Name: 2-((6S,8S,9R,10S,11S,13S,14S,16R,17R)-1,2-Dichloro-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.